Sol Gel Technologies (SLGL) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Sol Gel Technologies in October 2026.
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Sol Gel Technologies (SLGL) Stock Forecast
Analyst price target, next 12 months
$40.67
-41.4% vs today's $69.45
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Sol Gel Technologies have a consensus 12-month target of $40.67, below the current price of $69.45.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 May 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying SOL GEL's stock, expecting it to rise towards a target price of $40.67.
Financial Health
SOL GEL TECHNOLOGIES is generating modest revenue and cash flow, but its financial position needs improvement.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
